Original article
Impact of systemic inflammatory markers in patients with ALK-positive non-small cell lung cancer treated with crizotinib
O.F. Olmeza, A. Bilicia, P. Gursoyb, E. Cubukcuc, A. Sakind, T. Korkmaze, I. Cilf, B. Cakarb, S. Menekseg, T. Demirh, O. Acikgoza, J. Hamdarda,
Corresponding author
olmezof@gmail.com
Corresponding author at: Department of Medical Oncology, Medipol University Faculty of Medicine, Istanbul, Turkey.
Corresponding author at: Department of Medical Oncology, Medipol University Faculty of Medicine, Istanbul, Turkey.
a Department of Medical Oncology, Medipol University Faculty of Medicine, Istanbul, Turkey
b Ege University Faculty of Medicine, Izmir, Turkey
c Uludag University Faculty of Medicine, Bursa, Turkey
d University of Health Sciences Okmeydani Training and Research Hospital, Istanbul, Turkey
e Acıbadem University Faculty of Medicine, Istanbul, Turkey
f Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey
g Bagcilar Training and Research Hospital, Istanbul, Turkey
h Bezmialem University Faculty of Medicine, Istanbul; Turkey
Read
1587
Timeswas read the article
623
Total PDF
964
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 April | 65 | 27 | 92 |
| 2024 March | 87 | 36 | 123 |
| 2024 February | 76 | 30 | 106 |
| 2024 January | 76 | 42 | 118 |
| 2023 December | 111 | 64 | 175 |
| 2023 November | 171 | 124 | 295 |
| 2023 October | 18 | 43 | 61 |
| 2023 September | 20 | 32 | 52 |
| 2023 August | 20 | 20 | 40 |
| 2023 July | 27 | 27 | 54 |
| 2023 June | 61 | 17 | 78 |
| 2023 May | 42 | 32 | 74 |
| 2023 April | 32 | 26 | 58 |
| 2023 March | 55 | 22 | 77 |
| 2023 February | 21 | 19 | 40 |
| 2023 January | 47 | 37 | 84 |
| 2022 December | 35 | 25 | 60 |
Show all
